A BIOMARKER FOR DIAGNOSING MUSCULAR DYSTROPHIES, A PHARMACEUTICAL COMPOSITION FOR DIAGNOSING MUSCULAR DYSTROPHIES BY MEASURING THE EXPRESSION LEVEL OF THE BIOMARKER, AND A METHOD FOR SCREENING CANDIDATES FOR TREATING MUSCULAR DYSTROPHIES USING THE MARKER

摘要

Provided in the present invention are a biomarker for diagnosing muscular dystrophy, a pharmaceutical composition for diagnosing muscular dystrophy for measuring expression level of the biomarker, a method for measuring expression level of the biomarker for providing information needed for diagnosis of muscular dystrophy, and a method for screening a candidate drug for treating muscular dystrophy by measuring expression level of the biomarker. The biomarker composition for diagnosing muscular dystrophy comprises Fbkw7 beta, and has increased expression in myoblast compared with a normal person.